RxSight (RXST) Cash from Operations (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RxSight | 215.82 Mn | -2.06 Mn | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -875.90% |
| Dec 31, 2025 | 5.98% |
| Sep 30, 2025 | 72.87% |
| Jun 30, 2025 | 50.45% |
| Mar 31, 2025 | -107.32% |
| Dec 31, 2024 | -755.38% |
| Sep 30, 2024 | 116.14% |
| Jun 30, 2024 | 56.74% |
| Mar 31, 2024 | -12.14% |
| Dec 31, 2023 | -4.00% |
| Sep 30, 2023 | -5.78% |
| Jun 30, 2023 | 57.52% |
| Mar 31, 2023 | -28.22% |
| Dec 31, 2022 | 8.78% |
| Sep 30, 2022 | -2.46% |
| Jun 30, 2022 | 1.08% |
| Mar 31, 2022 | -71.81% |
| Dec 31, 2021 | 36.59% |
| Sep 30, 2021 | -14.83% |
| Jun 30, 2021 | -16.85% |
| Mar 31, 2021 | -24.61% |
| Dec 31, 2020 | -18.41% |